INSPIREMD INC. - COMMON STOCK

InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures

13 فبراير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 فبراير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

21 يناير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025

12 ديسمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)

09 ديسمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors

25 نوفمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update

12 نوفمبر 2024 07:00:01 بحسب Nasdaq GlobeNewswire

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

08 نوفمبر 2024 17:30:03 بحسب Nasdaq GlobeNewswire

InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12th

04 نوفمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System

15 أكتوبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent System

07 أكتوبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System

16 سبتمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update

06 أغسطس 2024 08:09:23 بحسب Nasdaq GlobeNewswire

InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment

05 أغسطس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

InspireMD to Report Second Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, August 6th

30 يوليو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million

01 يوليو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024  

28 مايو 2024 08:53:00 بحسب Nasdaq GlobeNewswire

InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update

14 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14th

07 مايو 2024 07:00:01 بحسب Nasdaq GlobeNewswire

InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference

03 أبريل 2024 08:59:14 بحسب Nasdaq GlobeNewswire